Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q86TM3 (
cage
)
29,987
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ctf18-replication factor C complex including Dscc1 (DNA replication and sister chromatid cohesion 1) is implicated in sister chromatid cohesion, DNA replication, and genome stability in S. cerevisiae and C. elegans. We previously performed gene expression profiling in primary colorectal cancer cells in order to identify novel molecular targets for the treatment of colorectal cancer. A feature of the
cancer-associated
transcriptional signature revealed from this effort is the elevated expression of the proto-oncogene
DSCC1
. Here, we have interrogated the molecular basis for deviant expression of human
DSCC1
in colorectal cancer and its ability to promote survival of cancer cells. Quantitative PCR and immunohistochemical analyses corroborated that the expression level of
DSCC1
is elevated in 60-70% of colorectal tumors compared to their matched noncancerous colonic mucosa. An in silico evaluation of the presumptive
DSCC1
promoter region for consensus DNA transcriptional regulatory elements revealed a potential role for the E2F family of DNA-binding proteins in controlling
DSCC1
expression. RNAi-mediated reduction of E2F1 reduced expression of
DSCC1
in colorectal cancer cells. Gain- and loss-of-function experiments demonstrated that
DSCC1
is involved in the viability of cancer cells in response to genotoxic stimuli. We reveal that E2F-dependent expression of
DSCC1
confers anti-apoptotic properties in colorectal cancer cells, and that its suppression may be a useful option for the treatment of colorectal cancer.
...
PMID:Overexpression of cohesion establishment factor DSCC1 through E2F in colorectal cancer. 2446 81